Burcon Announces Technology Advancements - Expands Protein Applications

VANCOUVER, Oct. 13 /CNW/ - Burcon NutraScience Corporation (TSX-V: BU) announces today that it has successfully developed modifications to its patented protein extraction process that improve the physical and functional properties of Puratein(R) and Supertein(TM) which is expected to enable their use in a broader array of food and beverage applications. Burcon and its license and development partner, Archer Daniels Midland ("ADM"), are working together to produce quantities of Puratein(R) and Supertein(TM) sufficient for further applications work and studies required for regulatory recognition, "GRAS status," for Puratein(R) and Supertein(TM) from the US Food and Drug Administration.

Burcon is also pleased to announce that, in relation to the process modifications now incorporated into Burcon's protein extraction technology, Burcon has filed additional patent applications over these novel new processing steps.

"Our team developed innovative modifications to our protein extraction technology, which have the potential to open up some exciting large-market food and beverage applications," stated Johann F. Tergesen, Burcon's President & COO who added, "As a result of these advancements, we are once again in a position to press forward on the regulatory recognition process for Puratein(R) and Supertein(TM)."

In the U.S., Canada, and Europe, new food ingredient products, which have heretofore not been consumed by humans in the amounts proposed under marketing efforts, must be assessed together with documentation supporting the new products' safety. Key components of this documentation are toxicology feeding studies. These studies are conducted with the product which will ultimately be marketed and which is produced using the defined final manufacturing process. Since both the process by which a new ingredient is produced and the resultant toxicology feeding trial results are connected, the toxicology feeding trials for Puratein(R) and Supertein(TM) could only be conducted after Burcon and ADM had determined the optimized extraction process by which the proteins will be produced.

Although Burcon has demonstrated to ADM the ability to produce proteins with improved physical and functional properties, the production thereof to-date has been limited to a small pilot-scale level. The two companies' development plans dictate that the new process now needs to be refined and optimized at an even larger scale in order to produce the samples sufficient for large-scale applications testing as well as for the important regulatory feeding trial studies. As such, Burcon and ADM have already scheduled additional large pilot-scale production tests at third-party facilities and are continuing research and development to improve and optimize Burcon's protein extraction process. The recently developed modifications are very encouraging, suggesting large-market food and beverage applications and imply that the parties can now re-initiate the regulatory recognition process. However, no assurance can be given: that Burcon and ADM's research and development activities will be successful, that the large pilot-sale production tests will result in suitable products, or that regulatory recognition of Burcon's proteins will ever be achieved.

About Burcon NutraScience
Burcon is a research and development company developing a portfolio of composition, application, and process patents around its plant protein extraction and purification technology. The goal of Burcon's research is to
develop its patented process to utilize inexpensive oilseed meals for the production of purified plant proteins that exhibit valuable nutritional, functional or nutraceutical profiles. Burcon, in conjunction with Archer
Daniels Midland, is currently focusing its efforts on developing the world's first commercial canola proteins, Puratein(R) and Supertein(TM). Canola, recognized for its nutritional qualities, is the second-largest oilseed crop in the world after soybeans. Burcon's goal is to develop Puratein and Supertein to participate with soy, dairy, and egg proteins in the expanding multi-billion-dollar protein ingredient market, with potential uses in
prepared foods, nutritional supplements, and personal care products.

The TSX Venture Exchange has not reviewed and does not accept
responsibility for the adequacy of the content of the information
contained herein.

This press release contains forward-looking statements that involve risks and uncertainties. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our products ,statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact. Our expectations regarding the prospect for future success depend upon our ability to develop and sell products, which we do not produce today and cannot be sold without further research and development. When used in this press release, the words "goal,""intend," "believes" and "potential" and similar expressions,,generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties. In light of the many risks and uncertainties surrounding the development of a source of protein from canola meal, you should understand that we cannot assure you that the forward looking statements contained in this press release will be realized.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.